30:I[53470,["352","static/chunks/352-3ee02a3105c218db.js","4166","static/chunks/4166-8ca60d5be3e3329a.js","6874","static/chunks/6874-98a7f8268e192452.js","5784","static/chunks/5784-415ddf12556d8261.js","7399","static/chunks/7399-26b15dbcfe6c3d55.js","3063","static/chunks/3063-7cbe9e548a8d185f.js","6164","static/chunks/6164-e17a771cf2d83f17.js","253","static/chunks/253-da62e547742b6bee.js","1215","static/chunks/1215-07120a8c77b23d78.js","5607","static/chunks/5607-9fccc14341fbf147.js","9164","static/chunks/9164-5de9886fbddf12ff.js","6252","static/chunks/6252-11d0c66f47fdb9a4.js","3204","static/chunks/3204-3dab2c3c5b4ac269.js","3470","static/chunks/3470-895a517adcd16c6c.js","4573","static/chunks/4573-0b6f4331c61ce283.js","3357","static/chunks/app/(storefront)/(main)/categories/%5B...category%5D/page-9d5cd25a3f84346f.js"],"default"] 31:T43f,

VisionMD® is an 1MD ophthalmologist-recommended eye health protocol developed with insights from the landmark AREDS2 study, to build a biological shield against modern blue light oxidative stress and the root drivers of age-related macular decline. Powered by 3 clinically studied and trademarked carotenoids like XanMax®, Zanthin®, and EVTene®, this formula is designed to support macular pigment density, visual acuity, and long-term ocular function.*

What to expect:

1 out of 3 users feel a reduction in eye fatigue and digital strain by 8 weeks^
60% of successful users notice improved visual acuity in as few as 12 weeks^
Nearly 3 out of 4 users report healthy vision clarity by week 12

Just 1 capsule, daily. Commit to a minimum of 16 weeks to achieve maximum efficacy.

^Based on a 2023 survey of over 90 VisionMD repeat customers. Customers were compensated for their survey participation.

Eye Health

VisionMD® Macular Health Protocol*